66 139

Cited 0 times in

Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older

 Ja Seo Koo  ;  Seong Hwan Moon  ;  Hankil Lee  ;  Sohee Park  ;  Yun Mi Yu  ;  Hye-Young Kang 
 PLOS ONE, Vol.15(12) : e0244759, 2020-12 
Journal Title
Issue Date
Aged ; Aged, 80 and over ; Bone Density ; Bone Density Conservation Agents / economics ; Bone Density Conservation Agents / therapeutic use* ; Female ; Humans ; Insurance, Health, Reimbursement* ; Middle Aged ; National Health Programs ; Osteoporosis / drug therapy* ; Osteoporosis / economics ; Osteoporotic Fractures / drug therapy* ; Osteoporotic Fractures / economics ; Policy ; Republic of Korea
Introduction: The Korean National Health Insurance revised its reimbursement criteria to expand coverage for anti-osteoporotic drug treatments in 2011 (expanding diagnostic criteria and the coverage period for anti-osteoporotic therapy) and 2015 (including osteoporotic fracture patients regardless of bone mineral density). We examined whether the two revisions contributed to an increase in the prescription rates of anti-osteoporotic drugs in Korea.

Methods: We used the Health Insurance Review and Assessment Service-National Patient Sample data from 2010 through 2016. A segmented regression analysis of interrupted time series was performed to assess changes in the monthly prescription rates of anti-osteoporotic drugs among women aged 50 or older, defined as the proportion of elderly women prescribed with anti-osteoporotic drugs.

Results: Both the levels (i.e., abrupt jump or drop) and the trends (i.e., slope) of the prescription rates of anti-osteoporotic drugs in the general population, osteoporotic patients, and osteoporotic fracture patients showed no significant changes after the first revision. However, there was a significant increase in the trends in the general population (β = 0.0166, p = 0.0173) and in osteoporotic patients (β = 0.1128, p = 0.0157) after the second revision. Women aged 65 to 79 years were the most significantly increased group in terms of the treatment proportion after the second revision because the trend was significant after the second revision in all three study populations (β = 0.0300, 0.1212, 0.1392, respectively; p < 0.05).

Conclusions: Although the two revisions expanded reimbursement coverage, only the second revision on reimbursing based on osteoporotic fracture regardless of bone mineral density was associated with increasing the proportion of post-menopausal women being treated with anti-osteoporotic drugs.
Files in This Item:
T202006649.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Orthopedic Surgery (정형외과학교실) > 1. Journal Papers
4. Graduate School of Public Health (보건대학원) > Graduate School of Public Health (보건대학원) > 1. Journal Papers
Yonsei Authors
Moon, Seong Hwan(문성환)
Park, So Hee(박소희) ORCID logo https://orcid.org/0000-0001-8513-5163
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.